Heartflow, Inc. Common Stock
Financials
Valuation Metrics
Heartflow, Inc. Common Stock's Market Cap is $4.38B. At end of 2025 it was $10.74B. Ranked #1472 of 3,121 in US market (top 47%), #509 of 1,463 on NASDAQ (top 35%), #91 of 205 in Health Care Equipment & Services (top 44%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $4.38B | US#1,472/3,121 Sec#91/205 |
| Revenue | $212M | US#2,566/3,121 Sec#169/205 |
| Net Income | $-118M | US—/3,121 Sec—/205 |
| Total Assets | $344M | US#2,887/3,121 Sec#172/205 |
| Net Assets | $280M | US#2,558/3,121 Sec#147/205 |
| Employees | 843 | US#2,063/3,121 Sec#144/205 |
| Value | ||
| P/B | 15.65x | US#2,740/3,121 Sec#177/205 |
| P/S | 20.64x | US#2,846/3,121 Sec#197/205 |
| FCF Yield | -1.35% | US—/3,121 Sec—/205 |
| Profitability | ||
| ROE | -42.32% | US#2,645/3,121 Sec#164/205 |
| ROA | -34.36% | US#2,914/3,121 Sec#191/205 |
| Op. Margin | -34.31% | US#2,653/3,121 Sec#173/205 |
| Revenue Growth | 42.77% | US#281/3,121 Sec#16/205 |
| Financial Health | ||
| Debt Ratio | 23.14% | US#260/3,121 Sec#25/205 |
| Total Debt | $27M | US#2,712/3,121 Sec#165/205 |
| FCF | $-59M | US#2,545/3,121 Sec#181/205 |
| Cash | $34M | US#2,722/3,121 Sec#177/205 |
| Current Ratio | 5.08x | US#461/3,121 Sec#35/205 |
| Performance | ||
| 1Y Return | 56.25% | US#501/3,121 Sec#46/205 |
| 1M Return | 11.46% | US#253/3,121 Sec#36/205 |
| From 52W High | -2.82% | US#245/3,121 Sec#30/205 |
| 1Y MDD | -48.66% | US#2,404/3,121 Sec#146/205 |
| Trading | ||
| Volume | 4,953,909 shares | US#1,197/3,121 Sec#72/205 |
| Trading Value | $252M | US#1,110/3,121 Sec#81/205 |
| Per Share | ||
| EPS | $-1.37 | US—/3,121 Sec—/205 |
| BPS | $3.24 | US#2,462/3,121 Sec#159/205 |
Company Info
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.